Delivery Order SPE2DR25D2109-SPE2DR26F5ZNF
Award Date 12/30/25
Potential Completion Date 12/31/25
Potential Value $65K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $91,716.73 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of September 29, 2025. This is a firm fixed-price, non-set-aside delivery order issued on September 27, 2025, with performance to take place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. ENBREL is a biologic immunosuppressant medication used to treat rheumatoid arthritis, psoriasis, and other...
- The Defense Logistics Agency awarded a delivery order valued at $13,758.06 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order was issued on September 5, 2025, with a completion deadline of September 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis...
- The Defense Logistics Agency awarded a $25,638.42 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions,...
- The Defense Logistics Agency awarded a delivery order valued at $18,617.73 to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with completion scheduled for October 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant used to treat rheumatoid arthritis and other inflammatory conditions, making this...
- The Defense Logistics Agency awarded a delivery order valued at $10,378.60 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors on November 10, 2025, with completion scheduled for November 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant used to treat rheumatoid arthritis and other...
- The Defense Logistics Agency awarded a delivery order valued at $61,490.24 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. ENBREL is a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions and is commonly stocked within...
- The Defense Logistics Agency awarded a $40,735.58 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of September 3, 2025. This non-set-aside award was issued on September 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other autoimmune conditions,...
- The Defense Logistics Agency awarded a $67,548.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors. The contract, which was competitively awarded with no set-aside designation, was executed on August 13, 2025, with an ultimate completion date of August 14, 2025. Performance will be conducted at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $259,099.12 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of September 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution operations. ENBREL is a...
- The Defense Logistics Agency awarded a $105,657.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with an ultimate completion date of October 28, 2025. This non-set-aside, competitively awarded contract represents a single delivery order fulfillment under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of...